Pregabalin Market 2023 : Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 

Top Key Players:

  • ZCL Chemicals
  • Olon S.p.A.
  • AASraw Biochemical Technology
  • Changzhou Pharmaceutical Factory (CPF)
  • Almelo Pvt. Ltd.
  • Divi’s Laboratories
  • Angels Pharma
  • ARITE Pharmaceutical
  • BAL Pharma
  • Bazayan
  • Aurobindo Pharma
  • Hikal
  • Glenmark Life Sciences
  • Dongbang FTL
  • Teva Pharmaceutical Industries
  • Divi’s Laboratories
  • Chemo Iberica
  • Maps Laboratories
  • Laurus Labs
  • Zhejiang Huahai Pharmaceutical
  • Vasudha Pharma Chem
  • Sun Pharmaceutical Industries
  • CTX Life Sciences
  • Srini Pharmaceuticals

Pregabalin Market By Applications

  • Hospitals
  • Clinics
  • Others

Pregabalin Market By Types

  • Tablet
  • Capsule
  • Oral Solution

Get a Sample PDF of report –https://www.360researchreports.com/enquiry/request-sample/21657398

What is the scenario for Marine Winch Industry?

Who are the prominent manufacturers of Metamaterial Industry?

What is the anticipated growth for the Cell Therapy Industry over the forecast duration 2023-2029?

What is the expected valuation of the Ketoconazole Industry by 2023-2029?